Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: back to .21 does not bode well for confidence - Emt

My only comment would be that in a patent portfolio, the patents that have the "broadest brush stroke" of claims are always the most important IMO. The more they encompass the more infringement is easier to ascertain and prove.

If in anyone's opinion the 336 encompasses more in it's claims then, by all means, that will be the one that the lawyers will push for when infringment/licensing talks begin with a potential licensee.

I could be all wrong in my statement that the 336 is broader and more encompassing than the 148, (it wouldn't be the first time I was wrong on something) but if I'm right and the lawyers(on both sides) see it that way too then IMO we'll be waiting a lot longer than we had hoped before we see a rash of licensing come to fruition, till that 336 reexam is complete.

JMHO

1
Jun 24, 2008 10:51AM
Share
New Message
Please login to post a reply